澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Control Bionics Ltd

0.059

+0.0011.72%

成交量：49.15萬

成交額：2.92萬

市值：3,204.22萬

市盈率：-2.85

高：0.063

開：0.063

低：0.057

收：0.058

52周最高：0.095

52周最低：0.032

股本：5.43億

流通股本：1.14億

量比：0.51

換手率：0.43%

股息：- -

股息率：- -

每股收益(TTM):-0.021

每股收益(LYR):-0.023

淨資產收益率：-91.56%

總資產收益率：-40.30%

市淨率：4.15

市盈率(LYR):-2.55

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Control Bionics 完成Neurostrip美國FDA註冊與設備列名

Control Bionics：設備交付後預計每年可產生250萬至350萬美元收入

Control Bionics披露客户意向：計劃每年採購大量基於iOS的語音生成設備

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/CBL.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CBL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CBL.AU\",,,,,undefined,":{"symbol":"CBL.AU","market":"AU","secType":"STK","nameCN":"Control Bionics Ltd","latestPrice":0.059,"timestamp":1787638320000,"preClose":0.058,"halted":0,"volume":491456,"delay":0,"changeRate":0.017241379310344723,"nameEN":"Control Bionics Ltd","floatShares":114482928,"shares":543088709,"eps":-0.020704,"marketStatus":"未開盤","change":0.001,"latestTime":"08-25 16:12:00 AEST","open":0.063,"high":0.063,"low":0.057,"amount":29241,"amplitude":0.103448,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.020704,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.058,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":0.5143283891775062,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CBL.AU","preClose":0.058,"auctionPrice":0.059,"auctionVolume":10000,"auction":3,"marketStatus":"盘后竞价","timestamp":1787638105431}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CBL.AU\",,,,,undefined,":{"symbol":"CBL.AU","floatShares":114482928,"roa":"-40.30%","roe":"-91.56%","lyrEps":-0.023131,"volumeRatio":0.5143283891775062,"shares":543088709,"dividePrice":0,"high":0.063,"amplitude":0.103448,"preClose":0.058,"low":0.057,"week52Low":0.032,"pbRate":"4.15","psRate":"5.28","week52High":0.095,"institutionHeld":0,"latestPrice":0.059,"eps":-0.020704,"divideRate":0,"volume":491456,"delay":0,"ttmEps":-0.020704,"open":0.063,"prevYearClose":0.061,"prevWeekClose":0.06,"prevMonthClose":0.064,"prevQuarterClose":0.074,"fiveDayClose":0.062,"twentyDayClose":0.063,"sixtyDayClose":0.059,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CBL.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2026-02-26","symbol":"CBL.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1772024400000,"reportTimeType":"","actualEps":null},{"market":"AU","date":"2025-09-01","symbol":"CBL.AU","defaultRemindTime":1756684800000,"type":"split","dateTimestamp":1756648800000,"forFactor":982905,"toFactor":1000000,"ratio":0.9829049999999999},{"date":"2025-07-31","symbol":"CBL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1753920000000,"name":null,"time":"","dateTimestamp":1753884000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CBL.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CBL.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1141091983","title":"Control Bionics 完成Neurostrip美國FDA註冊與設備列名","url":"https://stock-news.laohu8.com/highlight/detail?id=1141091983","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141091983?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 06:42","pubTimestamp":1785796948,"startTime":"0","endTime":"0","summary":"Control Bionics Ltd 近日宣布，已成功完成其Neurostrip产品在美国食品药品监督管理局的注册以及设备列名程序。从注册到列名，整个过程严格遵循了美国监管机构的标准，体现出Control Bionics对品质与安全的极高要求。对于投资者而言，这一进展无疑为Control Bionics的价值增长注入了新的动力。市场普遍预期，随着FDA的官方认可，Neurostrip将有望在更广泛的临床场景中得到应用，进而推动公司营收与品牌影响力的双重提升。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128703438","title":"Control Bionics：設備交付後預計每年可產生250萬至350萬美元收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1128703438","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128703438?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 05:23","pubTimestamp":1774473792,"startTime":"0","endTime":"0","summary":"Control Bionics Ltd（CBL.AU）宣布，其设备在完成交付后，预计每年将为公司带来250万至350万美元的稳定营收。这一预期收入规模凸显了公司产品在商业化阶段的增长潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183029885","title":"Control Bionics披露客户意向：計劃每年採購大量基於iOS的語音生成設備","url":"https://stock-news.laohu8.com/highlight/detail?id=1183029885","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183029885?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 05:23","pubTimestamp":1774473791,"startTime":"0","endTime":"0","summary":"Control Bionics Ltd宣布，其一位客户已明确表示，计划每年向公司采购数量可观的基于iOS操作系统的语音生成设备。这一采购意向凸显了市场对该公司创新辅助技术产品的持续需求，也预示着其核心业务在未来可能实现显著增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CBL.AU\",params:#limit:6,delay:true,,,undefined,":[]}}